Female reproductive system neoplasm
MONDO:0021148A benign, precancerous, or malignant neoplasm that affects the female reproductive system. Representative examples include uterine corpus leiomyoma, endocervical polyp, ovarian carcinoma, cervical carcinoma, and endometrial carcinoma.
Also known as: female reproductive organ neoplasm (disease), female reproductive organ tumor, female reproductive organ tumour, female reproductive system neoplasm, female reproductive system neoplasm (disease), female reproductive system tumor, female reproductive system tumour, gynecologic neoplasm
3680 clinical trials for this condition and its sub-types, 27 tagged with Female reproductive system neoplasm itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Female reproductive system neoplasm
-
Female reproductive organ cancer 245 trials · 2,252 incl. sub-types
9 sub-types
- Uterine cancer 95 trials · 1,261 incl. sub-types Sub-types →
- Ovarian cancer 1,002 trials · 1,198 incl. sub-types Sub-types →
- Fallopian tube cancer 298 trials · 408 incl. sub-types Sub-types →
- Endometrioid adenocarcinoma 12 trials · 144 incl. sub-types Sub-types →
- Vulva cancer 88 trials · 102 incl. sub-types Sub-types →
- Vaginal cancer 53 trials · 60 incl. sub-types Sub-types →
- Adenosarcoma 0 trials · 2 incl. sub-types Sub-types →
- Gestational choriocarcinoma 0 trials · 1 incl. sub-types Sub-types →
- Adenocarcinofibroma 0 trials Sub-types →
-
Tumor of uterus 10 trials · 1,432 incl. sub-types
6 sub-types
- Uterine cancer 95 trials · 1,261 incl. sub-types Sub-types →
- Uterine cervix neoplasm 39 trials · 731 incl. sub-types Sub-types →
- Endometrium neoplasm 478 trials · 687 incl. sub-types Sub-types →
- Corpus uteri neoplasm 1 trial · 191 incl. sub-types Sub-types →
- Uterine benign neoplasm 3 trials · 112 incl. sub-types Sub-types →
- Placenta neoplasm 0 trials · 6 incl. sub-types Sub-types →
-
Ovarian neoplasm 78 trials · 1,213 incl. sub-types
8 sub-types
- Ovarian cancer 1,002 trials · 1,198 incl. sub-types Sub-types →
- Ovarian epithelial tumor 14 trials · 664 incl. sub-types Sub-types →
- Ovarian germ cell tumor 9 trials · 13 incl. sub-types Sub-types →
- Ovarian sex cord-stromal tumor 1 trial · 7 incl. sub-types Sub-types →
- Ovarian benign neoplasm 1 trial Sub-types →
- Ovarian endometrioid stromal and related neoplasms 0 trials
- Ovarian melanoma 0 trials
- Rete ovarii neoplasm 0 trials Sub-types →
-
Fallopian tube neoplasm 199 trials · 417 incl. sub-types
5 sub-types
- Fallopian tube cancer 298 trials · 408 incl. sub-types Sub-types →
- Fallopian tube mucinous tumor 1 trial · 10 incl. sub-types Sub-types →
- Fallopian tube endometrioid tumor 3 trials
- Fallopian tube benign neoplasm 0 trials Sub-types →
- Fallopian tube germ cell tumor 0 trials Sub-types →
-
Benign female reproductive system neoplasm 5 trials · 117 incl. sub-types
7 sub-types
- Uterine benign neoplasm 3 trials · 112 incl. sub-types Sub-types →
- Adenomyoma 1 trial · 3 incl. sub-types Sub-types →
- Ovarian benign neoplasm 1 trial Sub-types →
- Adenofibroma 0 trials Sub-types →
- Benign vaginal neoplasm 0 trials Sub-types →
- Fallopian tube benign neoplasm 0 trials Sub-types →
- Vulvar benign neoplasm 0 trials Sub-types →
-
Vulvar neoplasm 6 trials · 107 incl. sub-types
9 sub-types
- Vulva cancer 88 trials · 102 incl. sub-types Sub-types →
- Vulvar squamous neoplasm 0 trials · 28 incl. sub-types Sub-types →
- Vulvar glandular neoplasm 0 trials · 5 incl. sub-types Sub-types →
- Bartholin gland neoplasm 0 trials · 1 incl. sub-types Sub-types →
- Clitoris neoplasm 0 trials Sub-types →
- Germ cell tumor of the vulva 0 trials Sub-types →
- Paraurethral gland neoplasm 0 trials Sub-types →
- Vulvar benign neoplasm 0 trials Sub-types →
- Vulvar granular cell tumor 0 trials
-
Endometrioid tumor 1 trial · 89 incl. sub-types
1 sub-type
- Ovarian endometrial cancer 4 trials · 88 incl. sub-types Sub-types →
-
Vaginal neoplasm 2 trials · 61 incl. sub-types
7 sub-types
- Vaginal cancer 53 trials · 60 incl. sub-types Sub-types →
- Vaginal squamous tumor 0 trials · 8 incl. sub-types Sub-types →
- Vaginal glandular neoplasm 0 trials · 7 incl. sub-types Sub-types →
- Vaginal melanoma 1 trial
- Benign vaginal neoplasm 0 trials Sub-types →
- Endometrioid stromal and related neoplasms of the vagina 0 trials Sub-types →
- Extraovarian Brenner tumor of the vagina 0 trials
-
Gestational trophoblastic neoplasm 7 trials · 8 incl. sub-types
6 sub-types
- Gestational choriocarcinoma 0 trials · 1 incl. sub-types Sub-types →
- Hydatidiform mole, recurrent, 1 1 trial
- Epithelioid trophoblastic tumor 0 trials
- Hydatidiform mole, recurrent, 2 0 trials
- Invasive hydatidiform mole 0 trials
- Placental site trophoblastic tumor 0 trials
-
2 sub-types
-
1 sub-type
Most studied deeper sub-types
-
Can engineered immune cells outsmart Drug-Resistant ovarian cancer?
Cure OngoingThis phase 1 trial tests an experimental therapy called AB-1015 in people with ovarian, fallopian tube, or primary peritoneal cancer that has stopped responding to platinum-based chemotherapy. AB-1015 uses a patient's own T cells, which are genetically engineered to recognize and…
Phase 1 • Sponsor: Arsenal Biosciences, Inc. • Aim: Cure
Last updated Sep 05, 2026 00:00 UTC
-
New drug targets rare cancer mutation in early trial
Disease control OngoingThis early-phase study tests a new oral drug, ATV-1601, in people with advanced solid tumors or certain breast cancers that have a specific AKT1 E17K mutation. The main goals are to check safety, find the right dose, and see how the drug moves through the body. About 134 adults w…
Phase 1 • Sponsor: Atavistik Bio, Inc • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New targeted drug shows promise for rare cancer mutation
Disease control OngoingThis early-stage trial tests a new drug, ALTA2618, in about 110 adults whose advanced solid tumors (like breast or endometrial cancer) have a specific genetic change called AKT1 E17K. The main goals are to check the drug's safety and find the right dose. Participants must have tr…
Phase 1 • Sponsor: Alterome Therapeutics, Inc. • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Experimental cell therapy for advanced gynecological cancers halted before start
Disease control CancelledThis study aimed to test an experimental treatment called GT316, made from a patient's own immune cells (tumor-infiltrating lymphocytes), for advanced gynecological cancers. The goal was to check the safety and side effects of this cell therapy. However, the study was withdrawn b…
Sponsor: Grit Biotechnology • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Immunotherapy duo takes on rare cancers
Disease control OngoingThis Phase 2 trial is testing whether combining two immunotherapy drugs, ipilimumab and nivolumab, can shrink or control rare cancers that are known to respond to immunotherapy. The study includes 240 people with advanced biliary tract, neuroendocrine, gynecologic, or MSI-H solid…
Phase 2 • Sponsor: Olivia Newton-John Cancer Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Virtual yoga and dance therapy tested to fight cancer fatigue
Symptom relief OngoingThis study is testing whether a 12-week virtual program of mind-body classes (like yoga, dance therapy, and tai chi) can reduce fatigue and improve quality of life for people with head and neck, thoracic, gynecologic, or other cancers. About 480 adults currently receiving cancer …
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated Aug 28, 2026 00:00 UTC
-
New study tests At-Home programs to ease pain and anxiety after cancer surgery
Symptom relief OngoingThis study compares two different remote support programs to see which one helps women feel better after surgery for suspected gynecological cancer. About 160 women will take part, and researchers will measure pain, mood, and sleep quality. The goal is to find simple, at-home way…
Phase 3 • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
New website aims to ease tough fertility choices for women with cancer
Knowledge-focused OngoingThis study tests a decision aid website called Pathways to Fertility for women newly diagnosed with cancer who may face infertility from treatment. About 130 women will use the website or receive standard care to see if it helps them make more informed and less conflicted decisio…
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Virtual therapy trial for cancer fear pulled before starting
Knowledge-focused CancelledThis trial was designed to test whether an online mental health program could help women with advanced gynecologic or breast cancer manage their fear of the cancer returning or getting worse. The study planned to compare the online program to standard educational materials. Howev…
Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC